ResearcherErasmus MCActive in the last 2 years
Willem de Koning
Matched on ORCID iD 0000-0002-4594-8423; OpenAlex author ID A5071702017. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 29
2021: 2 papers · 2022: 3 papers · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 9
- Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibroblast subsets associated with survival and … Co-author DOI 10.1016/j.ctarc.2026.101490↗
- Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationwide prospective cohort study. Co-author DOI 10.1016/j.ejca.2025.116065↗
- A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.ejca.2022.12.024↗
- Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients. Co-author DOI 10.3390/cancers15174349↗
- Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I stud… Co-author DOI 10.1016/j.ejca.2022.03.015↗
- Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microenvironment of long-term survivors. Co-author DOI 10.3389/fimmu.2022.995715↗
- Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced P… Co-author DOI 10.3390/cancers14215299↗
- Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes. Co-author DOI 10.3389/fimmu.2021.649061↗
- Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in Cancer Patients? Co-author DOI 10.3390/cancers13122896↗
Closest collaborators
The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Casper H.J. van Eijck · 9 shared papers, 2021–2026 · strength 1.56
- Paper Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibrobla… DOI 10.1016/j.ctarc.2026.101490↗
- Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
- Paper Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pa… DOI 10.3390/cancers15174349↗
- Dana A. M. Mustafa · 7 shared papers, 2021–2023 · strength 1.06
- Paper Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pa… DOI 10.3390/cancers15174349↗
- Paper A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with panc… DOI 10.1016/j.ejca.2022.12.024↗
- Paper Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes. DOI 10.3389/fimmu.2021.649061↗
- Gaby J. Strijk · 3 shared papers, 2023–2026 · strength 0.69
- Paper Bulk RNA sequencing deconvolution of early-onset pancreatic ductal adenocarcinoma identifies cancer-associated fibrobla… DOI 10.1016/j.ctarc.2026.101490↗
- Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
- Paper Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pa… DOI 10.3390/cancers15174349↗
- Bas Groot Koerkamp · 2 shared papers, 2023–2025 · strength 0.39
- Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
- Paper A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with panc… DOI 10.1016/j.ejca.2022.12.024↗
- Marjolein Y.V. Homs · 2 shared papers, 2023–2025 · strength 0.39
- Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
- Paper A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with panc… DOI 10.1016/j.ejca.2022.12.024↗
- Fleur van der Sijde · 2 shared papers, 2023 · strength 0.38
- Paper Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pa… DOI 10.3390/cancers15174349↗
- Paper A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with panc… DOI 10.1016/j.ejca.2022.12.024↗
- Casper W.F. van Eijck · 2 shared papers, 2023 · strength 0.38
- Paper Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries-Profiling Blood Samples of Pa… DOI 10.3390/cancers15174349↗
- Paper A multigene circulating biomarker to predict the lack of FOLFIRINOX response after a single cycle in patients with panc… DOI 10.1016/j.ejca.2022.12.024↗
- Michail Doukas · 2 shared papers, 2022–2025 · strength 0.32
- Paper Clinical relevance of next-generation sequencing in patients aged 60 years or younger with pancreatic cancer: A Nationw… DOI 10.1016/j.ejca.2025.116065↗
- Paper Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patient… DOI 10.1016/j.ejca.2022.03.015↗
- Yunlei Li · 2 shared papers, 2021–2022 · strength 0.30
- Paper Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes. DOI 10.3389/fimmu.2021.649061↗
- Paper Spatial genomics reveals a high number and specific location of B cells in the pancreatic ductal adenocarcinoma microen… DOI 10.3389/fimmu.2022.995715↗
- Lukas J.A.C. Hawinkels · 1 shared paper, 2026 · strength 0.30
- Bram W. van Os · 1 shared paper, 2026 · strength 0.30
- Nicole Dam · 1 shared paper, 2026 · strength 0.30
- Vera Kemp · 1 shared paper, 2026 · strength 0.30
- Leonoor V. Wismans · 2 shared papers, 2021–2022 · strength 0.25
- Paper Rintatolimod Induces Antiviral Activities in Human Pancreatic Cancer Cells: Opening for an Anti-COVID-19 Opportunity in… DOI 10.3390/cancers13122896↗
- Paper Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patient… DOI 10.1016/j.ejca.2022.03.015↗
- Sai Ping Lau · 2 shared papers, 2022 · strength 0.25
- Paper Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-… DOI 10.3390/cancers14215299↗
- Paper Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patient… DOI 10.1016/j.ejca.2022.03.015↗
- Johanna W. Wilmink · 1 shared paper, 2025 · strength 0.20
- Jelle C. van Dongen · 1 shared paper, 2025 · strength 0.20
- Judith de Vos‐Geelen · 1 shared paper, 2025 · strength 0.20
- Ignace H. J. T. de Hingh · 1 shared paper, 2025 · strength 0.20
- Nigel G. Kooreman · 1 shared paper, 2025 · strength 0.20
- Lodewijk A.A. Brosens · 1 shared paper, 2025 · strength 0.20
- Hosein M. Aziz · 1 shared paper, 2022 · strength 0.15
- Kostandinos Sideras · 1 shared paper, 2022 · strength 0.15
- Jaime Feliú · 1 shared paper, 2022 · strength 0.15
- Bernadette G. van den Hoogen · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.